Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Biopsychosocial Impact of Mepolizumab in Severe Eosinophilic Asthma on Quantitative and Qualitative Emotional and Affective Outcomes in Patients and Partners

NCT04680611 is registered in ClinicalTrials.gov with University Hospital Southampton NHS Foundation Trust as lead sponsor.

NCT NCT04680611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04680611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Biopsychosocial Impact of Mepolizumab in Severe Eosinophilic Asthma on Quantitative and Qualitative Emotional and Affective Outcomes in Patients and Partners
Lead sponsor
University Hospital Southampton NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
September 9, 2021
Completion date
March 26, 2025
Enrollment
120 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

adjustment, adjustment, emotional, anxiety, coping behavior, depression, emotional disorder, emotional distress, emotional dysfunction, emotions, psychological, psychological adjustment, psychological disorder, psychological distress, psychological stress, psychosocial problem, psychosocial stressor, severe eosinophilic asthma